TY  - CHAP
M1  - Book, Section
TI  - Coagulation and Platelet Disorders
A1  - Dushenkov, Anna
A1  - Jungsuwadee, Paiboon
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
Y1  - 2022
N1  - 
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Describe  the  basics  of  the  regulation  of  hemostasis  and  thrombosis.Select  appropriate  nonpharmacological  and  pharmacological  therapy  for  a  patient  with  hemophilia  in  a  given  clinical  situation.Calculate  an  appropriate  factor-concentrate  dose  for  a  product,  given  the  percentage  correction  desired  based  on  clinical  situation.List  possible  complications  from  hemophilia-induced  bleeding  episodes.Choose  an  appropriate  treatment  strategy  for  patients  with  factor  VIII  or  IX  inhibitors.Devise  a  treatment  plan  for  a  patient  with  a  specific  variant  of  von  Willebrand  disease  (vWD).Describe  various  recessively  inherited  coagulation  disorders  (RICDs)  and  the  role  of  specific  factor  replacement  in  RICD  management.Recommend  first-and  second-line  treatment  approaches  for  immune  thrombocytopenia  (ITP).Identify  basic  clinical  features,  causes,  and  management  of  select  thrombotic  microangiopathies  (TMAs).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/25
UR  - ppp.mhmedical.com/content.aspx?aid=1187026130
ER  -